XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.2
Financial Statements Details (Tables)
6 Months Ended
Jun. 30, 2024
Balance Sheet Components [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash The reconciliation of cash, cash equivalents and restricted cash reported on the unaudited condensed consolidated balance sheets to the total of the same such amounts in the unaudited condensed consolidated statements of cash flows is as follows (in thousands):
June 30, 2024December 31, 2023
Cash and cash equivalents$2,429,031 $1,938,606 
Restricted cash included in other assets868 858 
 Total cash, cash equivalents and restricted cash$2,429,899 $1,939,464 
Schedule of Accounts Receivable, Net Accounts receivable, net consists of the following (in thousands):
June 30, 2024December 31, 2023
Accounts receivable $1,237,629 $1,034,480 
Product sales rebate and returns reserve(10,834)(9,911)
   Accounts receivable, net $1,226,795 $1,024,569 
Schedule of Inventories Inventories consist of the following (in thousands):
June 30, 2024December 31, 2023
Raw materials $771,354 $930,777 
Finished goods 1,082,422 1,014,403 
   Total inventories $1,853,776 $1,945,180 
Schedule of Property and Equipment, Net Property and equipment, net consists of the following (in thousands):
June 30, 2024December 31, 2023
Land$45,883 $44,645 
Equipment and machinery 153,755 144,850 
Computer hardware and software 59,248 57,761 
Leasehold improvements
34,686 34,584 
Furniture and fixtures 3,557 3,576 
Construction-in-process 3,391 4,242 
    Property and equipment, gross 300,520 289,658 
Less: accumulated depreciation (204,238)(188,078)
    Property and equipment, net $96,282 $101,580 
Schedule of Accrued Liabilities Accrued liabilities consist of the following (in thousands):
June 30, 2024December 31, 2023
Accrued compensation-related costs$103,312 $134,225 
Accrued supplier liability80,350 167,878 
Accrued manufacturing costs56,693 61,491 
Accrued product development costs36,802 1,041 
Other42,914 42,667 
   Total accrued liabilities $320,071 $407,302 
Schedule of Contract Assets, Contract Liabilities and Deferred Revenue The following table summarizes the activity related to our contract liabilities (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Contract liabilities, beginning balance$139,618 $105,047 $133,239 $103,448 
Less: Revenue recognized from beginning balance(12,412)(9,941)(29,171)(22,105)
Less: Beginning balance reclassified to deferred revenue(6,917)(4,962)(6,012)(4,145)
Add: Contract liabilities recognized23,841 19,953 46,074 32,899 
Contract liabilities, ending balance$144,130 $110,097 $144,130 $110,097 
The following table summarizes the activity related to our deferred revenue (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Deferred revenue, beginning balance
$1,663,242 $1,092,274 $1,506,204 $1,041,246 
Less: Revenue recognized from beginning balance(249,938)(263,353)(467,516)(395,056)
Add: Deferral of revenue in current period, excluding amounts recognized during the period705,482 255,983 1,080,098 438,714 
Deferred revenue, ending balance$2,118,786 $1,084,904 $2,118,786 $1,084,904 
Schedule of Other Income (Expense), Net Other income (expense), net consists of the following (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Interest income$71,448 $32,206 $135,271 $54,715 
Gain (loss) on strategic investments— 24,743 — 19,172 
Other income (expense), net(585)(610)(1,788)(5,402)
    Total$70,863 $56,339 $133,483 $68,485